Cost-effectiveness of staging laparoscopy with peritoneal cytology in pancreatic adenocarcinoma

Curr Probl Surg. 2024 Mar;61(3):101442. doi: 10.1016/j.cpsurg.2024.101442. Epub 2024 Jan 18.

Authors

Maya Jodidio¹, Neal S Panse¹, Vishnu Prasath², Ronak Trivedi³, Simran Arjani³, Ravi J Chokshi⁴

Affiliations

¹ Division of Surgical Oncology, Department of Surgery, Rutgers New Jersey Medical School, Newark, NJ.
² Rutgers New Jersey Medical School, Newark, NJ; Department of Medicine, The Ohio State University College of Medicine, Columbus, OH.
³ Rutgers New Jersey Medical School, Newark, NJ.
⁴ Division of Surgical Oncology, Department of Surgery, Rutgers New Jersey Medical School, Newark, NJ. Electronic address: [email protected].

PMID: 38462312
DOI: 10.1016/j.cpsurg.2024.101442

No abstract available

MeSH terms

Adenocarcinoma* / pathology
Adenocarcinoma* / surgery
Cost-Benefit Analysis
Cytodiagnosis
Humans
Laparoscopy*
Neoplasm Staging
Pancreatic Neoplasms* / pathology
Pancreatic Neoplasms* / surgery
Stomach Neoplasms*